Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Lars Fruergaard Jørgensen - Wikipedia

    en.wikipedia.org/wiki/Lars_Fruergaard_Jørgensen

    Employer. Novo Nordisk (since 1994) Lars Fruergaard Jørgensen (born 29 November 1966) [ 1] is a Danish businessman, the Chief Executive of Novo Nordisk since January 2017 and Chairman of the European Federation of Pharmaceutical Industries and Associations . He was named as the Financial Times Person of the Year in December 2023.

  3. Lars Rebien Sørensen - Wikipedia

    en.wikipedia.org/wiki/Lars_Rebien_Sørensen

    October 10, 1954 (age 69) Education. The Royal Veterinary and Agricultural University, University of Copenhagen. Occupation (s) Former CEO at Novo Nordisk, chair of Novo Nordisk Foundation (2020. Employer. Novo Nordisk (until 2016) Lars Rebien Sørensen (born 10 October 1954) [1] is a Danish businessman and former CEO of the pharmaceutical ...

  4. Novo Nordisk - Wikipedia

    en.wikipedia.org/wiki/Novo_Nordisk

    Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd [ 3] with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.

  5. Novo Nordisk's unique structure gives it an extra edge — and ...

    www.aol.com/finance/novo-nordisks-unique...

    The Novo Nordisk Foundation didn't return Yahoo Finance's request to be interviewed for this story. Allie Garfinkle is a Senior Tech Reporter at Yahoo Finance. Follow her on X, formerly Twitter ...

  6. Novo Nordisk to build $220 million raw materials plant ... - AOL

    www.aol.com/novo-nordisk-pharmatech-unit-build...

    August 16, 2024 at 1:31 AM. OSLO (Reuters) -Novo Nordisk's Pharmatech unit will build a 1.5 billion Danish crowns ($220.83 million) plant in Denmark to meet significantly higher demand for the ...

  7. Lotte Bjerre Knudsen - Wikipedia

    en.wikipedia.org/wiki/Lotte_Bjerre_Knudsen

    Lotte Bjerre Knudsen. Lotte Bjerre Knudsen (born March 10, 1964) is a Danish scientist and university professor. She led the development of liraglutide and semaglutide, [third-party source needed] two notable drugs approved for indications in the treatment of diabetes and obesity. [ 1] [third-party source needed]

  8. Novo Nordisk plans record expansion in NC, promising 1,000 ...

    www.aol.com/novo-nordisk-plans-record-expansion...

    June 24, 2024 at 3:06 PM. Novo Nordisk announced the largest private life science investment in state history Monday, committing $4.1 billion to expand its Johnston County facility, a project the ...

  9. Hans Christian Hagedorn - Wikipedia

    en.wikipedia.org/wiki/Hans_Christian_Hagedorn

    Hans Christian Hagedorn (6 March 1888 – 6 October 1971) was the creator of NPH insulin and the founder of Nordisk Insulinlaboratorium, which is known today as Novo Nordisk. Early life and education [ edit ]